Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Cantor Fitzgerald reiterated its Overweight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreGuggenheim reiterated its Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreLeerink Partners reiterated its Market Perform rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreBernstein reiterated its Market Perform rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreTruist Securities reiterated its Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on November 02, 2026.
Read moreBTIG reiterated its Buy rating on Howmet Aerospace Inc. (NYSE:HWM) on November 02, 2026.
Read moreJefferies reiterated its Buy rating on Howmet Aerospace Inc. (NYSE:HWM) on November 02, 2026.
Read moreOppenheimer reiterated its Outperform rating on The PNC Financial Services Group, Inc. (NYSE:PNC) on November 02, 2026.
Read moreOppenheimer reiterated its Outperform rating on U.S. Bancorp (NYSE:USB) on November 02, 2026.
Read moreStephens & Co. reiterated its Overweight rating on CRH plc (NYSE:CRH) on November 02, 2026.
Read moreCitigroup reiterated its Buy rating on CRH plc (NYSE:CRH) on November 02, 2026.
Read moreDA Davidson reiterated its Buy rating on CRH plc (NYSE:CRH) on November 02, 2026.
Read moreWedbush analysts initiated coverage on Spring Valley Acquisition Corp. III (NASDAQ:SVACU) with a rating of Neutral on November 03, 2026.
Read moreNeedham reiterated its Buy rating on Backblaze, Inc. (NASDAQ:BLZE) on November 03, 2026.
Read moreNeedham reiterated its Buy rating on Ibotta, Inc. (NYSE:IBTA) on November 03, 2026.
Read moreRaymond James analysts downgraded D.R. Horton, Inc.
Read more
